Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Matthew Mossanen, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Yu A, Wang Y, Mossanen M, Preston M, Carvalho FL, Chung BI, Chang SL. Robotic-assisted radical cystectomy is associated with lower perioperative mortality in octogenarians. Urol Oncol. 2021 Sep 30. PMID: 34602361.
    Citations:    Fields:    
  2. Montazeri K, Dranitsaris G, Thomas JD, Curran C, Preston MA, Steele GS, Kilbridge KL, Mantia C, Ravi P, McGregor BA, Mossanen M, Sonpavde G. An economic analysis comparing health care resource use and cost of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin versus gemcitabine and cisplatin as neoadjuvant therapy for muscle invasive bladder cancer. Urol Oncol. 2021 Jun 20. PMID: 34162500.
    Citations:    Fields:    
  3. Chou WH, McGregor B, Schmidt A, Carvalho FLF, Hirsch MS, Chang SL, Kibel A, Mossanen M. Cyclophosphamide-associated bladder cancers and considerations for survivorship care: A systematic review. Urol Oncol. 2021 10; 39(10):678-685. PMID: 34134927.
    Citations:    Fields:    
  4. Matulewicz RS, Bjurlin MA, Carvalho FL, Mossanen M, El-Shahawy O. Best practices for assessing and reporting tobacco use in urology oncology practice and research. Urol Oncol. 2021 08; 39(8):446-451. PMID: 34078582.
    Citations:    Fields:    
  5. Ravi P, Pond GR, Diamantopoulos LN, Su C, Alva A, Jain RK, Skelton WP, Gupta S, Tward JD, Olson KM, Singh P, Grunewald CM, Niegisch G, Lee JL, Gallina A, Bandini M, Necchi A, Mossanen M, McGregor BA, Curran C, Grivas P, Sonpavde GP. Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration. BJU Int. 2021 Nov; 128(5):607-614. PMID: 33909949.
    Citations:    Fields:    
  6. Sha ST, Dee EC, Mossanen M, Mahal BA, Zaslowe-Dude C, Royce TJ, Hirsch MS, Sonpavde G, Preston MA, Nguyen PL, Mouw KW, Muralidhar V. Clinical characterization of radiation-associated muscle-invasive bladder cancer. Urology. 2021 Aug; 154:208-214. PMID: 33857569.
    Citations: 1     Fields:    
  7. Haeuser L, Herzog P, Ayub A, Nguyen DD, Noldus J, Cone EB, Mossanen M, Trinh QD. Comparison of comorbidity indices for prediction of morbidity and mortality after major surgical procedures. Am J Surg. 2021 Apr 14. PMID: 33888281.
    Citations:    Fields:    
  8. Mossanen M. The Epidemiology of Bladder Cancer. Hematol Oncol Clin North Am. 2021 Jun; 35(3):445-455. PMID: 33958144.
    Citations: 2     Fields:    
  9. Tan WS, Marchese M, Paciotti M, Nguyen DD, Cone EB, Mossanen M, Webster JJ, Barod R, Bex A, Kibel AS, Chang SL, Trinh QD. Delay in surgery for cT1b-2 kidney cancer beyond 90 days is associated with poorer survival: implications for prioritization during the COVID-19 pandemic. Minerva Urol Nephrol. 2021 06; 73(3):404-406. PMID: 33781018.
    Citations:    
  10. Paciotti M, Nguyen DD, Modonutti D, Haeuser L, Lipsitz S, Mossanen M, Kibel AS, Lughezzani G, Trinh QD, Cole AP. Impact of high-intensity local treatment on overall survival in stage IV upper tract urothelial carcinoma. Urol Oncol. 2021 07; 39(7):436.e1-436.e10. PMID: 33736978.
    Citations: 1     Fields:    
  11. Tully KH, Reese SW, Cole AP, Noldus J, Mossanen M, Trinh QD. Temporal trends in the incidence of distant-stage bladder cancer among young individuals. Int J Urol. 2021 06; 28(6):704-705. PMID: 33719127.
    Citations:    Fields:    Translation:Humans
  12. Haeuser L, Marchese M, Schrag D, Trinh QD, Chang SL, Kibel AS, Gore JL, Noldus J, Mossanen M. The impact of smoking on radical cystectomy complications increases in elderly patients. Cancer. 2021 05 01; 127(9):1387-1394. PMID: 33351967.
    Citations:    Fields:    
  13. Wymer KM, Sharma V, Saigal CS, Chamie K, Litwin MS, Packiam VT, Mossanen M, Pagliaro LC, Borah BJ, Boorjian SA. Cost-Effectiveness Analysis of Pembrolizumab for Bacillus Calmette-Guérin-Unresponsive Carcinoma In Situ of the Bladder. J Urol. 2021 May; 205(5):1326-1335. PMID: 33347775.
    Citations:    Fields:    Translation:Humans
  14. Huynh MJ, Wang Y, Joshi M, Krasnow R, Yu AX, Mossanen M, Chung BI, Chang SL. Patient factors predict complications after partial nephrectomy: validation and calibration of the Preoperative Risk Evaluation for Partial Nephrectomy (PREP) score. BJU Int. 2021 03; 127(3):369-374. PMID: 32920933.
    Citations: 1     Fields:    Translation:Humans
  15. Tully KH, Cole AP, Krimphove MJ, Friedlander DF, Mossanen M, Herzog P, Noldus J, Sonpavde GP, Trinh QD. Contemporary Treatment Patterns for Non-muscle-invasive Bladder Cancer: Has the Use of Radical Cystectomy Changed in the BCG Shortage Era? Urology. 2021 Jan; 147:199-204. PMID: 32805294.
    Citations: 1     Fields:    
  16. Huynh MJ, Wang Y, Chang SL, Tully KH, Chung BI, Wright JL, Mossanen M. The cost of obesity in radical cystectomy. Urol Oncol. 2020 12; 38(12):932.e9-932.e14. PMID: 32620482.
    Citations:    Fields:    Translation:Humans
  17. Tan WS, Wang Y, Trinh QD, Preston MA, Kelly JD, Hrouda D, Kibel AS, Krasnow RE, Liu JJ, Chung BI, Chang SL, Mossanen M. Delayed blood transfusion is associated with mortality following radical cystectomy. Scand J Urol. 2020 Aug; 54(4):290-296. PMID: 32538224.
    Citations:    Fields:    Translation:Humans
  18. Huang JT, Cole AP, Mossanen M, Preston MA, Wang Y, Kibel AS, Chung BI, Huang WJ, Chang SL. AUTHOR REPLY. Urology. 2020 Jun; 140:121. PMID: 32456860.
    Citations:    Fields:    
  19. Huang JT, Cole AP, Mossanen M, Preston MA, Wang Y, Kibel AS, Chung BI, Huang WJ, Chang SL. Alvimopan Is Associated With a Reduction in Length of Stay and Hospital Costs for Patients Undergoing Radical Cystectomy. Urology. 2020 Jun; 140:115-121. PMID: 32268172.
    Citations:    Fields:    
  20. Tully KH, Roghmann F, Noldus J, Chen X, Häuser L, Kibel AS, Sonpavde GP, Mossanen M, Trinh QD. Quantifying the Overall Survival Benefit With Early Radical Cystectomy for Patients With Histologically Confirmed T1 Non-muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2020 12; 18(6):e651-e659. PMID: 32335060.
    Citations:    Fields:    Translation:Humans
  21. Rodin D, Chien AT, Ellimoottil C, Nguyen PL, Kakani P, Mossanen M, Rosenthal M, Landrum MB, Sinaiko AD. Physician and facility drivers of spending variation in locoregional prostate cancer. Cancer. 2020 04 15; 126(8):1622-1631. PMID: 31977081.
    Citations:    Fields:    Translation:Humans
  22. Mossanen M, Chang SL. Beyond bladder cancer surveillance: building a survivorship clinic. BJU Int. 2020 01; 125(1):2-3. PMID: 31901010.
    Citations:    Fields:    Translation:HumansPHPublic Health
  23. Reese SW, Ji E, Paciotti M, Leow JJ, Mahvi DA, Steele G, Urman RD, Whang EE, Kibel AS, Mossanen M. Risk factors and reasons for reoperation after radical cystectomy. Urol Oncol. 2020 04; 38(4):269-277. PMID: 31761610.
    Citations: 2     Fields:    Translation:Humans
  24. Tully KH, Krimphove Md MJ, Huynh MJ, Marchese M, Kibel AS, Noldus J, Kluth LA, McGregor B, Chang SL, Trinh QD, Mossanen M. Differences in survival and impact of adjuvant chemotherapy in patients with variant histology of tumors of the renal pelvis. World J Urol. 2020 Sep; 38(9):2227-2236. PMID: 31748954.
    Citations:    Fields:    Translation:Humans
  25. Fletcher SA, Cole AP, Lu C, Marchese M, Krimphove MJ, Friedlander DF, Mossanen M, Kilbridge KL, Kibel AS, Trinh QD. The impact of underinsurance on bladder cancer diagnosis, survival, and care delivery for individuals under the age of 65 years. Cancer. 2020 02 01; 126(3):496-505. PMID: 31626340.
    Citations: 4     Fields:    Translation:Humans
  26. Tully KH, Krimphove MJ, Reese SW, Kibel AS, Noldus J, Krasnow RE, Trinh QD, Sonpavde GP, Chang SL, Mossanen M. Trends in Adherence to Thromboprophylaxis Guideline in Patients Undergoing Radical Cystectomy. Urology. 2020 Jan; 135:44-49. PMID: 31586570.
    Citations: 1     Fields:    Translation:Humans
  27. Nayak JG, Scalzo N, Chu A, Shiff B, Kearns JT, Dy GW, Macleod LC, Mossanen M, Ellis WJ, Lin DW, Wright JL, True LD, Gore JL. The development and comparative effectiveness of a patient-centered prostate biopsy report: a prospective, randomized study. Prostate Cancer Prostatic Dis. 2020 03; 23(1):144-150. PMID: 31462701.
    Citations: 1     Fields:    Translation:Humans
  28. Krimphove MJ, Szymaniak J, Marchese M, Tully KH, D'Andrea D, Mossanen M, Lipsitz SR, Kilbridge K, Kibel AS, Kluth LA, Shariat SF, Trinh QD. Sex-specific Differences in the Quality of Treatment of Muscle-invasive Bladder Cancer Do Not Explain the Overall Survival Discrepancy. Eur Urol Focus. 2021 01; 7(1):124-131. PMID: 31227463.
    Citations: 4     Fields:    
  29. Butler SS, Mahal BA, Lamba N, Mossanen M, Martin NE, Mouw KW, Nguyen PL, Muralidhar V. Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer. Cancer. 2019 09 15; 125(18):3164-3171. PMID: 31150125.
    Citations: 5     Fields:    Translation:Humans
  30. McClintock TR, Wang Y, Shah MA, Mossanen M, Chung BI, Chang SL. Hospital Charges for Urologic Surgery Episodes of Care Are Rising Despite Declining Costs. Mayo Clin Proc. 2019 06; 94(6):995-1002. PMID: 31079963.
    Citations:    Fields:    Translation:Humans
  31. Mossanen M, Kibel AS. The bladder cancer conundrum: how do we treat the right tumour with the right treatment, at the right time? BJU Int. 2019 05; 123(5):748-749. PMID: 31008564.
    Citations:    Fields:    Translation:Humans
  32. Mossanen M, Krasnow RE, Zlatev DV, Tan WS, Preston MA, Trinh QD, Kibel AS, Sonpavde G, Schrag D, Chung BI, Chang SL. Examining the relationship between complications and perioperative mortality following radical cystectomy: a population-based analysis. BJU Int. 2019 07; 124(1):40-46. PMID: 30499636.
    Citations: 8     Fields:    Translation:Humans
  33. Berg S, D'Andrea D, Vetterlein MW, Cole AP, Fletcher SA, Krimphove MJ, Marchese M, Lipsitz SR, Sonpavde G, Noldus J, Shariat SF, Kibel AS, Trinh QD, Mossanen M. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter? Cancer. 2019 05 01; 125(9):1449-1458. PMID: 30620387.
    Citations: 8     Fields:    Translation:Humans
  34. Gartland RM, Alves K, Brasil NC, Mossanen M, Mort E, Wright CD, Lubitz CC, May C. Does overlapping surgery result in worse surgical outcomes? A systematic review and meta-analysis. Am J Surg. 2019 07; 218(1):181-191. PMID: 30553459.
    Citations:    Fields:    Translation:Humans
  35. Mossanen M, Wang Y, Szymaniak J, Tan WS, Huynh MJ, Preston MA, Trinh QD, Sonpavde G, Kibel AS, Chang SL. Evaluating the cost of surveillance for non-muscle-invasive bladder cancer: an analysis based on risk categories. World J Urol. 2019 Oct; 37(10):2059-2065. PMID: 30446799.
    Citations: 9     Fields:    Translation:Humans
  36. Kearns JT, Winters BD, Holt SK, Mossanen M, Lin DW, Wright JL. Pathologic Nodal Involvement in Patients With Penile Cancer With Cavernosal Versus Spongiosal Involvement. Clin Genitourin Cancer. 2019 Feb; 17(1):e156-e161. PMID: 30448105.
    Citations: 2     Fields:    Translation:Humans
  37. Royce TJ, Feldman AS, Mossanen M, Yang JC, Shipley WU, Pandharipande PV, Efstathiou JA. Comparative Effectiveness of Bladder-preserving Tri-modality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer. Clin Genitourin Cancer. 2019 Feb; 17(1):23-31.e3. PMID: 30482661.
    Citations: 6     Fields:    Translation:Humans
  38. Krasnow RE, Rodríguez D, Nagle RT, Mossanen M, Kibel AS, Chang SL. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies. Urol Oncol. 2018 11; 36(11):500.e11-500.e19. PMID: 30249519.
    Citations: 3     Fields:    Translation:Humans
  39. Mossanen M, Caldwell J, Sonpavde G, Lehmann LS. Treating Patients With Bladder Cancer: Is There an Ethical Obligation to Include Smoking Cessation Counseling? J Clin Oncol. 2018 Nov 10; 36(32):3189-3191. PMID: 30212292.
    Citations:    Fields:    
  40. Mossanen M, Chu A, Smith AB, Gore JL. Inferring bladder cancer research prioritization from patient-generated online content. World J Urol. 2019 Jun; 37(6):1145-1150. PMID: 30203340.
    Citations: 3     Fields:    Translation:Humans
  41. Ha A, Krasnow RE, Mossanen M, Nagle R, Hshieh TT, Rudolph JL, Chang SL. A contemporary population-based analysis of the incidence, cost, and outcomes of postoperative delirium following major urologic cancer surgeries. Urol Oncol. 2018 Jul; 36(7):341.e15-341.e22. PMID: 29801992.
    Citations: 6     Fields:    Translation:Humans
  42. Mossanen M, Nepple KG, Grubb RL, Androile GL, Kallogjeri D, Klein EA, Stephenson AJ, Kibel AS. Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy. Eur Urol Oncol. 2018 06; 1(2):143-148. PMID: 31100238.
    Citations: 5     Fields:    Translation:Humans
  43. Mossanen M, Chang SL, Kimm S, Sonpavde GP, Kibel AS. Current Staging Strategies for Muscle-Invasive Bladder Cancer and Upper Tract Urothelial Cell Carcinoma. Urol Clin North Am. 2018 May; 45(2):143-154. PMID: 29650131.
    Citations: 3     Fields:    Translation:Humans
  44. Mossanen M, Brown JC, Schrag D. Well-being beyond the bladder. How do we improve the overall health of patients with bladder cancer? BJU Int. 2018 04; 121(4):489-491. PMID: 29603896.
    Citations: 2     Fields:    Translation:Humans
  45. Wang Y, Mossanen M, Chang SL. Cost and cost-effectiveness studies in urologic oncology using large administrative databases. Urol Oncol. 2018 04; 36(4):213-219. PMID: 29500134.
    Citations: 1     Fields:    
  46. Mossanen M, Kibel AS. Editorial Comment. J Urol. 2018 03; 199(3):712. PMID: 29253358.
    Citations:    Fields:    Translation:Humans
  47. Winters BR, Kearns JT, Holt SK, Mossanen M, Lin DW, Wright JL. Is there a benefit to adjuvant radiation in stage III penile cancer after lymph node dissection? Findings from the National Cancer Database. Urol Oncol. 2018 03; 36(3):92.e11-92.e16. PMID: 29174944.
    Citations: 3     Fields:    Translation:Humans
  48. Nayak JG, Holt SK, Wright JL, Mossanen M, Dash A, Gore JL. The impact of readmission hospital on failure-to-rescue rates following major urologic cancer surgery. Urol Oncol. 2018 04; 36(4):156.e1-156.e7. PMID: 29153941.
    Citations:    Fields:    Translation:Humans
  49. Mossanen M, Krasnow RE, Lipsitz SR, Preston MA, Kibel AS, Ha A, Gore JL, Smith AB, Leow JJ, Trinh QD, Chang SL. Associations of specific postoperative complications with costs after radical cystectomy. BJU Int. 2018 03; 121(3):428-436. PMID: 29063725.
    Citations: 6     Fields:    Translation:Humans
  50. Mossanen M, Smith AB. Addressing Financial Toxicity: The Role of the Urologist. J Urol. 2018 07; 200(1):43-45. PMID: 29113839.
    Citations: 4     Fields:    Translation:Humans
  51. Mossanen M, Krasnow RE, Nguyen PL, Trinh QD, Preston M, Kibel AS. Approach to the Patient with High-Risk Prostate Cancer. Urol Clin North Am. 2017 Nov; 44(4):635-645. PMID: 29107279.
    Citations: 2     Fields:    Translation:Humans
  52. Mossanen M, Preston MA. Quality Improvement Efforts in Radical Cystectomy: From Prehab to Rehab. Eur Urol. 2018 Mar; 73(3):372-373. PMID: 28867447.
    Citations: 1     Fields:    
  53. Mossanen M, Kibel AS, Goldman RH. Exploring exposure to Agent Orange and increased mortality due to bladder cancer. Urol Oncol. 2017 11; 35(11):627-632. PMID: 28826703.
    Citations:    Fields:    Translation:HumansPHPublic Health
  54. Leow JJ, Cole AP, Seisen T, Bellmunt J, Mossanen M, Menon M, Preston MA, Choueiri TK, Kibel AS, Chung BI, Sun M, Chang SL, Trinh QD. Variations in the Costs of Radical Cystectomy for Bladder Cancer in the USA. Eur Urol. 2018 Mar; 73(3):374-382. PMID: 28803034.
    Citations: 14     Fields:    
  55. Chaudhary MA, Leow JJ, Mossanen M, Chowdhury R, Jiang W, Learn PA, Weissman JS, Chang SL. Patient driven care in the management of prostate cancer: analysis of the United States military healthcare system. BMC Urol. 2017 Jul 11; 17(1):56. PMID: 28693554.
    Citations: 2     Fields:    Translation:Humans
  56. Krasnow RE, Mossanen M, Koo S, Kubiak DW, Preston MA, Chung BI, Kibel AS, Chang SL. Prophylactic Antibiotics and Postoperative Complications of Radical Cystectomy: A Population Based Analysis in the United States. J Urol. 2017 08; 198(2):297-304. PMID: 28267603.
    Citations: 6     Fields:    Translation:Humans
  57. Kim S, Bochatay N, Relyea-Chew A, Buttrick E, Amdahl C, Kim L, Frans E, Mossanen M, Khandekar A, Fehr R, Lee YM. Individual, interpersonal, and organisational factors of healthcare conflict: A scoping review. J Interprof Care. 2017 May; 31(3):282-290. PMID: 28276847.
    Citations: 6     Fields:    Translation:Humans
  58. Mossanen M, Holt S, Gore JL, Lin DW, Wright JL. 15 Years of penile cancer management in the United States: An analysis of the use of partial penectomy for localized disease and chemotherapy in the metastatic setting. Urol Oncol. 2016 12; 34(12):530.e1-530.e7. PMID: 27495001.
    Citations: 4     Fields:    Translation:Humans
  59. Winters BR, Mossanen M, Holt SK, Lin DW, Wright JL. Predictors of Nodal Upstaging in Clinical Node Negative Patients With Penile Carcinoma: A National Cancer Database Analysis. Urology. 2016 Oct; 96:29-34. PMID: 27450944.
    Citations: 9     Fields:    Translation:Humans
  60. Mossanen M, Macleod LC, Chu A, Wright JL, Dalkin B, Lin DW, True L, Gore JL. Comparative Effectiveness of a Patient Centered Pathology Report for Bladder Cancer Care. J Urol. 2016 11; 196(5):1383-1389. PMID: 27211289.
    Citations: 6     Fields:    Translation:Humans
  61. Nayak JG, Gore JL, Holt SK, Wright JL, Mossanen M, Dash A. Patient-centered risk stratification of disposition outcomes following radical cystectomy. Urol Oncol. 2016 May; 34(5):235.e17-23. PMID: 26749464.
    Citations: 6     Fields:    Translation:Humans
  62. Mossanen M, Dighe M, Gore J, Mann G. Large retroperitoneal hemangioma encompassing the renal vein. Can Urol Assoc J. 2015 Nov-Dec; 9(11-12):E894-6. PMID: 26834900.
    Citations:    
  63. Mossanen M, Calvert JK, Holt SK, James AC, Wright JL, Harper JD, Krieger JN, Gore JL. Overuse of antimicrobial prophylaxis in community practice urology. J Urol. 2015 Feb; 193(2):543-7. PMID: 25196654.
    Citations: 6     Fields:    Translation:Humans
  64. Mossanen M, Gore JL. The burden of bladder cancer care: direct and indirect costs. Curr Opin Urol. 2014 Sep; 24(5):487-91. PMID: 24887047.
    Citations: 37     Fields:    Translation:Humans
  65. Mossanen M, True LD, Wright JL, Vakar-Lopez F, Lavallee D, Gore JL. Surgical pathology and the patient: a systematic review evaluating the primary audience of pathology reports. Hum Pathol. 2014 Nov; 45(11):2192-201. PMID: 25149550.
    Citations: 8     Fields:    Translation:Humans
  66. Mossanen M, Johnston SS, Green J, Joyner BD. A practical approach to conflict management for program directors. J Grad Med Educ. 2014 Jun; 6(2):345-6. PMID: 24949146.
    Citations:    Fields:    
  67. Mossanen M, Calvert JK, Wright JL, True LD, Lin DW, Gore JL. Readability of urologic pathology reports: the need for patient-centered approaches. Urol Oncol. 2014 Nov; 32(8):1091-4. PMID: 24846343.
    Citations: 7     Fields:    Translation:Humans
  68. Hotaling JM, Leddy LS, Haider MA, Mossanen M, Bailey MR, MacConaghy B, Olson F, Krieger JN. Simple circumcision device: proof of concept for a single-visit, adjustable device to facilitate safe adult male circumcision. Fertil Steril. 2014 May; 101(5):1266-70. PMID: 24613534.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  69. Calvert JK, Holt SK, Mossanen M, James AC, Wright JL, Porter MP, Gore JL. Use and outcomes of extended antibiotic prophylaxis in urological cancer surgery. J Urol. 2014 Aug; 192(2):425-9. PMID: 24603103.
    Citations: 10     Fields:    Translation:Humans
  70. Mossanen M, Izard J, Wright JL, Harper JD, Porter MP, Daratha KB, Holt SK, Gore JL. Identification of underserved areas for urologic cancer care. Cancer. 2014 May 15; 120(10):1565-71. PMID: 24523042.
    Citations: 6     Fields:    Translation:Humans
  71. Mossanen M, Lee F, Cheng H, Harris W, Shenoi J, Zhao S, Wang J, Champion T, Izard J, Gore JL, Porter MP, Yu EY, Wright JL. Nonresponse to neoadjuvant chemotherapy for muscle-invasive urothelial cell carcinoma of the bladder. Clin Genitourin Cancer. 2014 Jun; 12(3):210-3. PMID: 24361053.
    Citations: 2     Fields:    Translation:Humans
  72. Hamilton J, Mossanen M, Strote J. Mondor's Disease of the Penis. West J Emerg Med. 2013 Mar; 14(2):180. PMID: 23599866.
    Citations: 6     Fields:    
  73. Breda A, Mossanen M, Leppert J, Harper J, Schulam PG, Churchill B. Percutaneous cystolithotomy for calculi in reconstructed bladders: initial UCLA experience. J Urol. 2010 May; 183(5):1989-93. PMID: 20303534.
    Citations: 5     Fields:    Translation:Humans
  74. Wiseman JE, Mossanen M, Ituarte PH, Bath JM, Yeh MW. An algorithm informed by the parathyroid hormone level reduces hypocalcemic complications of thyroidectomy. World J Surg. 2010 Mar; 34(3):532-7. PMID: 20049440.
    Citations: 20     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Mossanen's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (201)
Explore
_
Co-Authors (37)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.